Skip to main content

Table 1 Characteristics of patients with E. coli urosepsis

From: Short- and long-term mortality in patients with urosepsis caused by Escherichia coli susceptible and resistant to 3rd generation cephalosporins

 

All patients

N = 313

EC-SR group N = 195

(62.3)

EC-RC group

N = 118

(37.7)

P value

Age (years), mean (SD)

79 (12.0)

79 (12.8)

80 (10.7)

0.376

Sex (female) n (%)

199 (63.6)

136 (69.7)

63 (53.4)

0.004

Nursing care institution, n (%)

57 (18.2)

18 (9.2)

39 (33.1)

 < 0.001

Charlson score, mean (SD)

5.24 (2.18)

4.93 (2.27)

5.74 (1.92)

0.001

DM, (%)

133 (42.5)

83 (42.6)

50 (42.4)

0.974

BPH, n (%)

43 (13.7)

21 (10.8)

22 (18.6)

0.050

CRF, n (%)

50 (16.0)

22 (11.3)

28 (23.7)

0.004

Nephrolithiasis, n (%)

26 (8.3)

15 (7.7)

11 (9.3)

0.613

Urinary malignancy, n (%)

8 (2.6)

3 (1.5)

5 (4.2)

0.159

Permanent urinary catheter, n (%)

16 (5.1)

6 (3.1)

10 (8.5)

0.036

Recent urinary tract manipulation, n (%)

4 (1.3)

2 (1.0)

2 (1.7)

0.634

History of urinary retention, n (%)

6 (1.9)

3 (1.5)

3 (2.5)

0.676

History of recurrent UTI, n (%)

23 (7.3)

9 (4.6)

14 (11.9)

0.017

Previous hospitalization with EC-SC urosepsis, n (%)

7 (2)

4 (2)

3 (3)

1.0

Previous hospitalization with RC Enterobacteriaceae urosepsis, n (%)

18 (5.8)

6 (3.1)

12 (10.2)

0.009

Outpatient antibiotic therapy for UTI in the past 3 months, n (%)

25 (8.0)

4 (2.1

21 (17.8)

 < 0.001

  1. Data is presented as mean (SD) or number (%)
  2. EC-CS Group—patients with urosepsis caused by E. coli susceptible to 3rd generation cephalosporins
  3. EC-RC Group—patients with urosepsis caused by E. coli resistant to 3rd generations cephalosporins
  4. SD standard deviation, DM diabetes mellitus, BPH benign prostate hypertrophy, CRF chronic renal failure, UTI urinary tract infection, S/P status post